Skip to content

Investigating patient experiences of obtaining a diagnosis of severe asthma: the Severe Asthma Pathways Study

Investigating patient experiences of obtaining a diagnosis of severe asthma: the Severe Asthma Pathways Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12620001036909
Acronym
SAP Study
Enrollment
19
Registered
2020-10-12
Start date
2020-12-08
Completion date
2021-12-30
Last updated
2021-06-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This research aims to explore the journey undertaken by people with severe asthma in obtaining their severe asthma diagnosis. It has been reported that this diagnosis is often delayed and people with severe asthma experience symptoms for many years before they are diagnosed and able to access the most appropriate medicine for them. By exploring their journeys, this study aims to identify barriers to obtaining a severe asthma diagnosis and facilitating the development of a streamlined pathway for the future.

Interventions

People with severe asthma will be interviewed about their experiences in obtaining a severe asthma diagnosis. It is anticipated that there will only be a single exposure to the patient but given the nature of qualitative research, follow up exposures may be necessary to further explore interview topics to prevent interview fatigue and in depth exploration of topics. The patient will determine the length of each exposure based on their comfort levels. The anticipated maximum duration of a single

People with severe asthma will be interviewed about their experiences in obtaining a severe asthma diagnosis. It is anticipated that there will only be a single exposure to the patient but given the nature of qualitative research, follow up exposures may be necessary to further explore interview topics to prevent interview fatigue and in depth exploration of topics. The patient will determine the length of each exposure based on their comfort levels. The anticipated maximum duration of a single interview will be approximately 60 minutes to prevent interview fatigue and further interviews scheduled if necessary. The maximum number of interviews that a participant may be asked to complete to further explore interview topics will be three, e.g. maximum of three 60 minute interviews spaced one month apart. The participant is not required to complete any questionnaires, either online or in person. Topics covered in the interviews will include time taken to receive a diagnosis of severe asthma, number of specialists seen, symptoms experienced (onset/duration), interactions with primary health care including pharmacists and general practitioners. The overall duration of study participation when follow-up interviews are undertaken will be no longer than three months. Interviews will be conducted, via videoconference to allow for rapport to develop between interviewer and participant. HOWEVER, only audio recordings will be kept. The interviews will be conducted by a research assistant trained in qualitative interview techniques.

Sponsors

The Woolcock Institute of Medical Research
Lead SponsorOther

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

People with severe asthma that are able to speak English comfortably.

Exclusion criteria

None.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026